Wells Fargo & Company »

Lexeo Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $128k 19k 6.64
2025-06-30 $62k 15k 4.02
2025-03-31 $40k 11k 3.47
2024-12-31 $73k 11k 6.58
2024-09-30 $67k 7.4k 9.04
2024-06-30 $54k 3.3k 16.04
2024-03-31 $53k 3.4k 15.68
2023-12-31 $966 72 13.42